This inventor holds 1 USPTO granted patent. Top assignee: Allogene Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Spencer Park - Innovator in Cytokine Receptor Technology
Introduction
Spencer Park is a notable inventor based in Belmont, California. He has made significant contributions to the field of immunology through his innovative work on cytokine receptors. His research focuses on enhancing the functional activities of genetically modified immune cells.
Latest Patents
Spencer Park holds a patent for "Inducible Chimeric Cytokine Receptors." This invention provides inducible chimeric cytokine receptors that are responsive to a ligand, such as a small molecule or protein. The patent outlines the uses of these receptors for improving the functional activities of genetically modified immune cells, particularly T cells, which incorporate these inducible chimeric cytokine receptors.
Career Highlights
Spencer Park is currently employed at Allogene Therapeutics, Inc., where he continues to advance his research in the field of immunotherapy. His work is pivotal in developing new therapeutic strategies that leverage the power of genetically modified immune cells.
Collaborations
Some of his notable coworkers include Andrew Ross Nager and Javier Fernando Chaparro Riggers. Their collaboration contributes to the innovative environment at Allogene Therapeutics, Inc.
Conclusion
Spencer Park's contributions to the field of immunology through his patent on inducible chimeric cytokine receptors highlight his role as a leading inventor in advancing therapeutic technologies. His work continues to impact the development of innovative treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile